4.6 Article

Citations alone were enough to predict favorable conclusions in reviews of neuraminidase inhibitors

期刊

JOURNAL OF CLINICAL EPIDEMIOLOGY
卷 68, 期 1, 页码 87-93

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinepi.2014.09.014

关键词

Neuraminidase inhibitors; Bibliometrics; Evidence synthesis; Reviews as a topic; Citation analysis; Supervised machine learning

资金

  1. National Health and Medical Research Council [568612, 1045065]

向作者/读者索取更多资源

Objectives: To examine the use of supervised machine learning to identify biases in evidence selection and determine if citation information can predict favorable conclusions in reviews about neuraminidase inhibitors. Study Design and Setting: Reviews of neuraminidase inhibitors published during January 2005 to May 2013 were identified by searching PubMed. In a blinded evaluation, the reviews were classified as favorable if investigators agreed that they supported the use of neuraminidase inhibitors for prophylaxis or treatment of influenza. Reference lists were used to identify all unique citations to primary articles. Three classification methods were tested for their ability to predict favorable conclusions using only citation information. Results: Citations to 4,574 articles were identified in 152 reviews of neuraminidase inhibitors, and 93 (61%) of these reviews were graded as favorable. Primary articles describing drug resistance were among the citations that were underrepresented in favorable reviews. The most accurate classifier predicted favorable conclusions with 96.2% accuracy, using citations to only 24 of 4,574 articles. Conclusion: Favorable conclusions in reviews about neuraminidase inhibitors can be predicted using only information about the articles they cite. The approach highlights how evidence exclusion shapes conclusions in reviews and provides a method to evaluate citation practices in a corpus of reviews. (C) 2015 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据